Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Optimizing Patient Follow-Up in Urologic Oncology, With Jason Hafron, MD
2
Published data support PSMA-PET–guided selection for 177Lu-rosopatamab tetraxetan in mCRPC
3
Phase 3 trial launches of CAIX-targeted radiopharmaceutical for ccRCC
4
FDA grants tentative approval to generic olaparib tablets across previously approved indications
5